Ethel Rubin

CIK: 0002038290

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VNRX

VOLITIONRX LTD

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

VNRX
VOLITIONRX LTD
Feb 26, 2026
Award(A)
Direct
178K shares-
VNRX
VOLITIONRX LTD
Jan 22, 2026
Award(A)
Direct
12K shares-
VNRX
VOLITIONRX LTD
Aug 15, 2025
Award(A)
Direct
17.4K shares-
VNRX
VOLITIONRX LTD
Jun 1, 2025
Award(A)
Direct
12K shares-
VNRX
VOLITIONRX LTD
Mar 1, 2025
Award(A)
Direct
9.9K shares-
VNRX
VOLITIONRX LTD
Dec 1, 2024
Award(A)
Direct
8.6K shares-
VNRX
VOLITIONRX LTD
Sep 30, 2024
Award(A)
Direct
15K shares-

		Type	Shares	Price		Ownership
Feb 26, 2026	VNRX VOLITIONRX LTD	Award(A)	178,000	-	$0	Direct
Jan 22, 2026	VNRX VOLITIONRX LTD	Award(A)	12,000	-	$0	Direct
Aug 15, 2025	VNRX VOLITIONRX LTD	Award(A)	17,424	-	-	Direct
Jun 1, 2025	VNRX VOLITIONRX LTD	Award(A)	11,983	-	-	Direct
Mar 1, 2025	VNRX VOLITIONRX LTD	Award(A)	9,893	-	-	Direct
Dec 1, 2024	VNRX VOLITIONRX LTD	Award(A)	8,648	-	$0	Direct
Sep 30, 2024	VNRX VOLITIONRX LTD	Award(A)	15,000	-	$0	Direct

1-7 of 7 transactions

About Rubin Ethel

Rubin Ethel (SEC CIK 0002038290) files insider reports with the SEC as Director of VOLITIONRX LTD (VNRX).

Signal8 holds 8 ownership filings by Rubin Ethel (1 Form 3, 7 Form 4), filed between Sep 30, 2024 and Feb 27, 2026. Those filings report 7 transactions, from Sep 30, 2024 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rubin Ethel's filings is in HENDERSON, NV.

Recent filings by Rubin Ethel

Feb 26, 2026: Grant or award of VNRX shares (Form 4, code A).
Jan 22, 2026: Grant or award of VNRX shares (Form 4, code A).
Aug 15, 2025: Grant or award of VNRX shares (Form 4, code A).
Jun 1, 2025: Grant or award of VNRX shares (Form 4, code A).
Mar 1, 2025: Grant or award of VNRX shares (Form 4, code A).

Other insiders filing for VOLITIONRX LTD (VNRX)

Batchelor Ann-Louise, Group Chief Marketing Officer
Forterre Gael, Chief Commercial Officer
Rootsaert Rodney Gerard, Secretary
Micallef Jacob Vincent, Chief Scientific Officer
Plummer Nicholas, GC - Volition Diagnostics
Reynolds Cameron John, President and CEO

How to read Form 4 transaction codes